Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Association between cancer-specific adverse event triggers and mortality: a validation study.

Weingart SN, Nelson J, Koethe B, et al. Association between cancer‐specific adverse event triggers and mortality: A validation study. Cancer Med. 2020;9(12):4447-4459. doi:10.1002/cam4.3033.

Save
Print
May 20, 2020
Weingart SN, Nelson J, Koethe B, et al. Cancer Med. 2020;9(12):4447-4459.
View more articles from the same authors.

Using a cohort of adults diagnosed with breast, colorectal, lung or prostate cancer, this study examined the relationship between oncology-specific triggers and mortality. It found that patients with at least one trigger had a higher risk of death than patients without a trigger; this association was strongest for nonmetastatic prostate cancer and nonmetastatic colorectal cancer. Triggers most commonly associated with increased odds of mortality were bacteremia, blood transfusion, hypoxemia and nephrology consultation. These findings support the validity of cancer-specific trigger tool but additional research is needed to replicate these findings.

Save
Print
Cite
Citation

Weingart SN, Nelson J, Koethe B, et al. Association between cancer‐specific adverse event triggers and mortality: A validation study. Cancer Med. 2020;9(12):4447-4459. doi:10.1002/cam4.3033.